Hvsen Biotechnology Co., Ltd. announced a private placement to issue common shares on April 3, 2024. The transaction has been approved in the 10th meeting of the third board of directors and the 8th meeting of the third board of supervisors and still need to be reviewed and approved by the company's shareholders' meeting, reviewed and approved by the Shenzhen Stock Exchange, and approved by the China Securities Regulatory Commission for registration before they can be implemented.